Treatment of thrombotic thrombocytopenic purpura

Treatment of thrombotic thrombocytopenic purpura

Show other versions (1)

The review discusses approaches to treatment of acquired thrombotic thrombocytopenic purpuгa (aTTP). In patients with aTTP plasma exchanges, glucocorticosteroids allow to stop an acute attack of TTP, and use of rituximab allows to achieve remission. In recent years, caplacizumab has been used. Treat...

Full description

Bibliographic Details
Main Authors:	Gennadii M. Galstyan, Alexei A. Maschan, Elizaveta E. Klebanova, Irina I. Kalinina
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2021-06-01
Series:	Терапевтический архив
Subjects:	adamts13 thrombotic thrombocytopenic purpura pregnancy therapeutic plasma exchange rituximab cyclosporine a bortezomib n-acetylcysteine caplacizumab recombinant adamts13
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/75968/56559

Similar Items

Treatment of thrombotic thrombocytopenic purpura
by: Gennadii M. Galstyan, et al.
Published: (2021-07-01)

Updates on thrombotic thrombocytopenic purpura: Recent developments in pathogenesis, treatment and survivorship
by: Senthil Sukumar, et al.
Published: (2021-12-01)

Diagnosis of thrombotic thrombocytopenic purpura
by: G. M. Galstyan, et al.
Published: (2020-12-01)

Assessment and Monitoring of Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): Strategies to Improve Outcomes
by: Kucukyurt S, et al.
Published: (2020-09-01)

Clinical observation of a patient with thrombotic thrombocytopenic purpura with renal and intestinal lesions
by: A G Stolyar, et al.
Published: (2019-07-01)

Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy
by: Faisal Musa, et al.
Published: (2015-04-01)

Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura
by: Elverdi T, et al.
Published: (2019-04-01)

Unresponsive Thrombotic Thrombocytopenic Purpura (TTP): Challenges and Solutions
by: Lemiale V, et al.
Published: (2021-06-01)

COVID-19 infection triggering hrombotic thrombocytopenic purpura
by: Mohammad Alhomoud, et al.
Published: (2021-01-01)

Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura
by: Mari R. Thomas, et al.
Published: (2015-08-01)

Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management
by: Senthil Sukumar, et al.
Published: (2021-02-01)

Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report
by: Valter Romão de Souza, et al.
Published: (2018-01-01)

Thrombotic thrombocytopenic purpura patients' attitudes toward depression management: A qualitative study
by: Deirdra R. Terrell, et al.
Published: (2019-11-01)

Atypical Presentation of Thrombotic Thrombocytopenic Purpura without Hematological Features
by: Balraj Singh, et al.
Published: (2020-07-01)

A report of disseminated adenocarcinoma presenting as thrombotic thrombocytopenic purpura
by: Joaquín Valle Alonso, et al.
Published: (2011-10-01)

Presumed antiphospholipid syndrome and thrombotic thrombocytopenic purpura: An infrequent association
by: Hallie Hanna Dolin, et al.
Published: (2019-10-01)

Relapse of Immune Thrombotic Thrombocytopenic Purpura Following Vaccination with COVID19 mRNA Vaccine
by: Katerina Pavenski
Published: (2021-07-01)

Congenital Thrombotic Thrombocytopenic Purpura: Atypical Presentation And First ADAMTS 13 Mutation In A Tunisian Child
by: aida borgi
Published: (2013-06-01)

Evaluation of the Plasmic Score for the Prediction of Adamts13 Activity in Patients with Thrombotic Microangiopathies
by: Giovanni Tiscia, et al.
Published: (2018-07-01)

Diagnostic relevance of ADAMTS13 activity: Evaluation of 28 patients with thrombotic thrombocytopenic purpura - hemolytic uremic syndrome clinical diagnosis
by: Vučelić Dragica, et al.
Published: (2013-01-01)

A chronic recurrent course of moschcowitz disease
by: I I Kalinina, et al.
Published: (2008-07-01)

Thrombotic thrombocytopenic purpura - a disease with multiple organ manifestations. Diagnostic and therapeutic difficulties in clinical practice
by: Magdalena Szydełko, et al.
Published: (2018-07-01)

Immune-mediated thrombotic thrombocytopenic purpura in patients with and without systemic lupus erythematosus: a retrospective study
by: Cai Yue, et al.
Published: (2020-08-01)

Diagnosis and follow‐up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay
by: Nicolas Beranger, et al.
Published: (2021-01-01)

Bethesda Assay for Detecting Inhibitory Anti-ADAMTS13 Antibodies in Immune-Mediated Thrombotic Thrombocytopenic Purpura
by: Chiara Vendramin, et al.
Published: (2018-07-01)

Generation and validation of small ADAMTS13 fragments for epitope mapping of anti‐ADAMTS13 autoantibodies in immune‐mediated thrombotic thrombocytopenic purpura
by: Kadri Kangro, et al.
Published: (2020-07-01)

Clinical Features and Gene Mutation Analysis of Congenital Thrombotic Thrombocytopenic Purpura in Neonates
by: Jiali Wang, et al.
Published: (2020-09-01)

Identification of Biomarkers in Patients with Thrombotic Thrombocytopenic Purpura Presenting with Large and Small Ischemic Stroke
by: Chen Lin, et al.
Published: (2021-02-01)

Two novel mutations in ADAMTS13 in a Chinese boy with congenital thrombocytopenic purpura: a case report
by: Ling Hou, et al.
Published: (2020-03-01)

Hereditary Thrombotic Thrombocytopenic Purpura in a Chinese Boy With a Novel Compound Heterozygous Mutation of the ADAMTS13 Gene
by: Yi-ling Dai, et al.
Published: (2020-09-01)

Concentration and Subclass Distribution of Anti-ADAMTS13 IgG Autoantibodies in Different Stages of Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
by: György Sinkovits, et al.
Published: (2018-07-01)

Thrombotic Thrombocytopenic Purpura: Etiopathogenesis, Diagnostics and Basic Principles of Treatment
by: Todorović Željko, et al.
Published: (2017-03-01)

EB virus reactivation triggers thrombotic thrombocytopenic purpura in a healthy adult
by: Satoko Oka, et al.
Published: (2017-01-01)

Anti-ADAMTS13 Antibodies and a Novel Heterozygous p.R1177Q Mutation in a Case of Pregnancy-Onset Immune-Mediated Thrombotic Thrombocytopenic Purpura
by: Elien Roose, et al.
Published: (2018-01-01)

Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution
by: Constantine N. Logothetis, et al.
Published: (2021-07-01)

Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice
by: K. N. Grigoreva, et al.
Published: (2021-03-01)

Acquired thrombotic thrombocytopenia purpura associated with severe ADAMTS13 deficiency in a 3-year-old boy: a case report and review of the literature
by: Hamidah Alias, et al.
Published: (2018-09-01)

THROMBOTIC MICROANGIOPATHY IN HAEMATOPOIETIC CELL TRANSPLANTATION:AN UPDATE
by: Hillard Michael Lazarus, et al.
Published: (2010-08-01)

THROMBOTIC MICROANGIOPATHY IN HAEMATOPOIETIC CELL TRANSPLANTATION:AN UPDATE
by: Evi Stavrou, et al.
Published: (2010-10-01)

Microangiopatie trombotiche: classificazione e diagnosi differenziale
by: Giulia Antognoli, et al.
Published: (2016-08-01)